LMH STRATEGIC SOLUTIONS

Lobbying for EXELIXIS, INC. · Biotechnology company.

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income · posted Apr 17, 2026

Lobbying activity 2

Pharmacy

Prescription drug payment reform. Pharmaceutical supply chain.

Medicare/Medicaid

General Medicare and Medicaid Issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.